News from the FDA/CDC
News from the FDA/CDC
CDC chief lays out attack plan for COVID variants
Public health leaders are ramping up genome sequencing of the SARS-CoV-2 virus and ensuring that sampling is geographically representative.
News from the FDA/CDC
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Completed safety clinical trial shows occurrence of heart-related events and cancer in RA patients taking the Janus kinase inhibitor is higher...
News from the FDA/CDC
CDC panel: No COVID-19 vaccine safety surprises
News from the FDA/CDC
FDA approves voclosporin for lupus nephritis
The calcineurin inhibitor is the first oral treatment to be approved for lupus nephritis.
News
Anaphylaxis cases after COVID-19 vaccine rising but still rare: CDC
News from the FDA/CDC
CDC issues COVID-19 vaccine guidance for underlying conditions
The CDC guidance had specific information for people with ...
News from the FDA/CDC
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
The primary safety endpoint was to characterize the safety of the vaccine following one or two doses.
News from the FDA/CDC
FDA expands belimumab indication to adults with lupus nephritis
The approval is based on the BLISS-LN trial, in which belimumab, when added to standard therapy, increased response rates and prevented worsening...
News from the FDA/CDC
Vaccine rollout on track, expect 300 million doses through March: Feds
Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the U.S. by March 31.
News
FDA safety alert: Face masks with metal can burn during MRI
News
CDC panel delves into priorities for COVID vaccine distribution